Cargando…
Copy Number Variation in Inflammatory Breast Cancer
Identification of a unique genomic biomarker in de novo inflammatory breast cancer (IBC) may provide an insight into the biology of this aggressive disease. The goal of our study was to elucidate biomarkers associated with IBC. We examined breast biopsies collected from Dana–Farber Cancer Institute...
Autores principales: | Hazra, Aditi, O’Hara, Andrea, Polyak, Kornelia, Nakhlis, Faina, Harrison, Beth T., Giordano, Antonio, Overmoyer, Beth, Lynce, Filipa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093603/ https://www.ncbi.nlm.nih.gov/pubmed/37048158 http://dx.doi.org/10.3390/cells12071086 |
Ejemplares similares
-
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer
por: Garrido-Castro, Ana C., et al.
Publicado: (2023) -
SP33. Optimizing Patient Selection for Lympha in Patients with Inflammatory Breast Cancer
por: Hyland, Colby J., et al.
Publicado: (2023) -
D84. Pre-operative Lymphedema Risk Factors in Patients with Inflammatory Breast Cancer: Optimizing Patient Selection for LYMPHA
por: Hyland, Colby J., et al.
Publicado: (2023) -
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
por: Pernas, Sonia, et al.
Publicado: (2022) -
Contribution of Copy Number Variation in Idiopathic Hypogonadotropic Hypogonadism
por: Stamou*, Maria, et al.
Publicado: (2021)